| :: HOME :: CONTACT US :: | COPYRIGHT MPR DEVELOPMENT GROUP 2002- |
|---|
Early-Phase clinical research aims mainly to determine the effects of the drug for the first time on humans: how it is absorbed, metabolized and excreted. During this phase, researchers also investigate potential side effects that occur based on the dosage levels. These early phase studies on experimental drugs can show the potential and future benefits of new compounds. MPR understands the complexity of conducting Early Phase clinical trials and expanded capabilities to serve the research community in several locations. We currently support patient-based Early Phase clinical trials and plan to expand our capabilities to manage healthy-volunteer based studies.
Clinical Units
We support early phase projects via several units, geographically located to offer our customers accessibility to a large pool of volunteers with particular demographical characteristics. We follow centralized procedures and SOPs
Research Units – Michigan, USA
- 2 units used as per needed – almost 70 beds each
- Highly experienced staff with demonstrated research experience
- Emergency units close-by or in same facility building
- Lab services
- Dose ranging
- PK/Biostatistics
- Also, the Company is setting up a new 50 bed phase I unit in Michigan
- One clinical research unit - 20 beds, expandable to 70 beds
- Emergency Unit in the same building
- Lab services
- Pk/Pd
- Bioequivalence Centre
- One clinical research unit - 20 beds, expandable
- Emergency Unit within few miles from the building
- Lab services
- PK; Pd
- Biostatistics
- Bioequivalence Centre
- One clinical research unit - 120 beds
- Emergency Unit in the same building
- Lab services
- High enrollment rate
- Phase I Laboratory
- PK/Biostatistics
- Bioequivalence
- First-in-man center
Type of studies performed
Our phase I studies can offer a clear image about drug potential and benefits vs. side effects and safety. We can offer our customers the following type of studies:
- First-in-man (patient-volunteers)
- Safety and tolerability
- Single and multiple dose rising
- Development and use of Biomarkers
- Dose response relationship
- PK studies
- Drug to drug interactions
- Food to Drug interactions
- Bioavailability & Bioequivalence
Related Links